DYN vs V · $1.19B cap vs P/E 33, rev $40.00B
Dyne Therapeutics Inc (DYN) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
DYN does not have a complete income-statement cache yet.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
DYN currently screens at market cap $1.19B. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the DYN and V stock pages for the full models.
Not investment advice.